Skip to main content
. 2020 Jun 27;10(1):010424. doi: 10.7189/jogh.10.010424

Table 3.

Adherence to study interventions based on weekly caregiver reports

Adherence to supplementation* TZ PZ MNP CONTROL P value
N children
848
844
841
847

Preventive†
Total preventive tablets/sachets used, n (%)
183 762 (92.4)
179 299 (92.1)
166 009 (89.2)
178 116 (91.0)
<0.001
Therapeutic
Total therapeutic tablets given, n
8124
7972
7449
7962
0.46
Total number of diarrhea episodes reported
1128
1095
1091
1157

Days therapeutic tablet given per episode‡
6.8 ± 4.3
6.6 ± 3.9
6.2 ± 4.0
6.8 ± 4.7
0.10
Episodes treated (%)§
982 (87)
949 (87)
953 (87)
999 (86)
0.902
Tablet given within 10 days of initiation of treatment, n (%)
6177 (76)
6080 (76)
5842 (78)
6188 (77)
<0.01
Tablets given per treated episode
6.2 ± 3.0
6.2 ± 3.1
5.9 ± 3.3
6.2 ± 3.0
0.22
Days ORS used
2487
2705
2618
2651
0.47
Days ORS used per episode
0.64 ± 0.7
0.62 ± 0.7
0.63 ± 0.7
0.65 ± 0.7
0.95
Days treated with therapeutic tablet among children who never had diarrhea 787 804 717 732 0.73

TZ – therapeutic zinc, PZ – preventive zinc, MNP micronutrient powder, ORS – oral rehydration salt

*Excluded days for which the status of supplement intake was unknown.

†Adherence to preventive supplement defined as percentage of total observation days for which daily preventive supplement was given to the child.

‡The “days therapeutic tablet given per episode” include the total number of days the child took the therapeutic tablet regardless of whether or not is was given in relation to a diarrhea episode.

§A treat episode is defined as initiation of treatment (ie, consumption of the first tablet) within 7 days of the onset of diarrhea.